News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
674,774 Results
Type
Article (38677)
Company Profile (193)
Press Release (635904)
Section
Business (202936)
Career Advice (1965)
Deals (35372)
Drug Delivery (74)
Drug Development (80463)
Employer Resources (167)
FDA (15933)
Job Trends (14792)
News (342843)
Policy (32396)
Tag
Academia (2526)
Africa (712)
Allergies (37)
Alliances (48863)
Alzheimer's disease (1093)
Antibody-drug conjugate (ADC) (43)
Approvals (15876)
Arizona (159)
Artificial intelligence (48)
Asia (36592)
Australia (5949)
Bankruptcy (350)
Best Places to Work (11208)
Biosimilars (55)
C2C Services and Suppliers (78806)
California (820)
Canada (641)
Cancer (176)
Career advice (1640)
CAR-T (32)
Cell therapy (65)
China (48)
Clinical research (62589)
Collaboration (56)
Colorado (33)
Compensation (30)
COVID-19 (2452)
Cystic fibrosis (69)
Diabetes (32)
Diagnostics (5888)
Diversity, equity & inclusion (44)
Drug pricing (47)
Earnings (82790)
Employer resources (141)
Europe (78139)
Events (106953)
FDA (15977)
Florida (106)
Funding (37)
Gene therapy (52)
GLP-1 (465)
Government (4276)
Healthcare (18529)
Hotbed/Location (481130)
Idaho (55)
Illinois (194)
Indiana (105)
Infectious disease (2465)
Inflammatory bowel disease (83)
Interviews (307)
IPO (16116)
Job creations (3621)
Job search strategy (1415)
Kansas (90)
Layoffs (372)
Legal (7826)
Liver cancer (51)
Lung cancer (37)
Maine (47)
Management (53)
Manufacturing (45)
Maryland (251)
Massachusetts (450)
Medical device (12945)
Medtech (12948)
Mergers & acquisitions (18957)
Metabolic disorders (154)
Neuroscience (1170)
New Jersey (62)
New York (83)
NextGen Class of 2024 (6451)
Non-profit (4443)
North Carolina (158)
Obesity (101)
Opinion (161)
Parkinson's disease (29)
Patents (33)
Peanut (33)
Pennsylvania (55)
People (55558)
Phase I (19399)
Phase II (27572)
Phase III (20614)
Policy (33)
Postmarket research (2544)
Preclinical (8271)
Rare diseases (89)
Real estate (5880)
Recruiting (63)
Regulatory (21015)
Reports (32)
Research institute (2298)
Resumes & cover letters (344)
South America (1089)
Startups (3555)
Texas (87)
United States (3002)
Vaccines (408)
Washington State (113)
Weight loss (96)
Date
Today (45)
Last 7 days (496)
Last 30 days (1909)
Last 365 days (38275)
2024 (21608)
2023 (40093)
2022 (51191)
2021 (55736)
2020 (54102)
2019 (46560)
2018 (35044)
2017 (32152)
2016 (31525)
2015 (37575)
2014 (31331)
2013 (26349)
2012 (28577)
2011 (29266)
2010 (27329)
674,774 Results for "allergan inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-Ups
University Lab Partners (ULP) is thrilled to announce the return of the Golden Ticket pitch competition for aesthetic startups, proudly sponsored by Allergan Aesthetics, an AbbVie Company.
April 12, 2024
·
2 min read
Business
AbbVie and Allergan Aesthetics to Present New Data at 2024 Annual AAD Meeting Showcasing Depth and Strength Across Dermatology and Aesthetics Portfolios
AbbVie and Allergan Aesthetics, an AbbVie company, today announced they will present 29 abstracts, including three late-breaking presentations, during the 2024 American Academy of Dermatology (AAD) Annual Meeting, March 8-12, in San Diego, California.
March 6, 2024
·
34 min read
BioMidwest
SkinMedica® Celebrates 25 Years of Empowering Radiant Skin
Allergan Aesthetics, an AbbVie company, the makers of BOTOX® Cosmetic, is celebrating 25 years of SkinMedica®.
June 6, 2024
·
8 min read
Drug Development
Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from two pivotal Phase 3 clinical studies evaluating trenibotulinumtoxinE (BoNT/E) for the treatment of moderate to severe glabellar lines (M21-500 and M21-508).
October 24, 2023
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
3 min read
·
Voyager Therapeutics, Inc.
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”).
June 28, 2024
·
4 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
1 of 67,478
Next